California Governor Signs Bill That Specifies PGx Testing is Covered Under Medi-Cal

Pharmacogenetic testing is a covered benefit under the Medi-Cal program, subject to utilization controls and when supported by evidence-based clinical practice guidelines.

Medi-Cal is California’s healthcare coverage program for low-income residents, and AB 425 makes pharmacogenetic testing a covered benefit under this program starting July 1, 2024.